

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride catabolic process (GO:0019433) | 9.13031634 |
| 2 | neutral lipid catabolic process (GO:0046461) | 8.16989728 |
| 3 | acylglycerol catabolic process (GO:0046464) | 8.16989728 |
| 4 | regulation of sequestering of triglyceride (GO:0010889) | 7.83628204 |
| 5 | transcytosis (GO:0045056) | 6.48182216 |
| 6 | response to dietary excess (GO:0002021) | 6.44042567 |
| 7 | fatty acid homeostasis (GO:0055089) | 6.23506682 |
| 8 | glycerolipid catabolic process (GO:0046503) | 5.91328748 |
| 9 | NADH metabolic process (GO:0006734) | 5.62772915 |
| 10 | diacylglycerol metabolic process (GO:0046339) | 5.53653002 |
| 11 | lipid storage (GO:0019915) | 5.22959566 |
| 12 | white fat cell differentiation (GO:0050872) | 5.21926139 |
| 13 | brown fat cell differentiation (GO:0050873) | 5.02497391 |
| 14 | ethanol oxidation (GO:0006069) | 5.00244318 |
| 15 | plasma lipoprotein particle clearance (GO:0034381) | 4.85949045 |
| 16 | triglyceride biosynthetic process (GO:0019432) | 4.84330543 |
| 17 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.83693855 |
| 18 | lipid particle organization (GO:0034389) | 4.78860368 |
| 19 | ovulation from ovarian follicle (GO:0001542) | 4.77808584 |
| 20 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.75240654 |
| 21 | positive regulation of glomerulus development (GO:0090193) | 4.70510407 |
| 22 | negative regulation of amino acid transport (GO:0051956) | 4.69192524 |
| 23 | regulation of cholesterol storage (GO:0010885) | 4.65722702 |
| 24 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.63382495 |
| 25 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.63382495 |
| 26 | acylglycerol biosynthetic process (GO:0046463) | 4.62224460 |
| 27 | neutral lipid biosynthetic process (GO:0046460) | 4.62224460 |
| 28 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.62144261 |
| 29 | biotin metabolic process (GO:0006768) | 4.61261296 |
| 30 | oxaloacetate metabolic process (GO:0006107) | 4.48745946 |
| 31 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.46723782 |
| 32 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.42004018 |
| 33 | triglyceride metabolic process (GO:0006641) | 4.36811262 |
| 34 | protein heterotrimerization (GO:0070208) | 4.36278433 |
| 35 | primary alcohol metabolic process (GO:0034308) | 4.36254024 |
| 36 | negative regulation of macrophage differentiation (GO:0045650) | 4.32628529 |
| 37 | regulation of gonadotropin secretion (GO:0032276) | 4.29849463 |
| 38 | valine metabolic process (GO:0006573) | 4.25567971 |
| 39 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.19809717 |
| 40 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.17425999 |
| 41 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.11627864 |
| 42 | negative regulation of granulocyte differentiation (GO:0030853) | 4.07709504 |
| 43 | glycerol metabolic process (GO:0006071) | 4.04294175 |
| 44 | acylglycerol metabolic process (GO:0006639) | 4.03305026 |
| 45 | positive regulation of lipid storage (GO:0010884) | 4.00352743 |
| 46 | retinol metabolic process (GO:0042572) | 3.99135576 |
| 47 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.98420179 |
| 48 | cellular response to epinephrine stimulus (GO:0071872) | 3.98338267 |
| 49 | neutral lipid metabolic process (GO:0006638) | 3.97537869 |
| 50 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.89868096 |
| 51 | regulation of lipoprotein metabolic process (GO:0050746) | 3.84888627 |
| 52 | ethanol metabolic process (GO:0006067) | 3.82956446 |
| 53 | polyketide metabolic process (GO:0030638) | 3.82137559 |
| 54 | doxorubicin metabolic process (GO:0044598) | 3.82137559 |
| 55 | daunorubicin metabolic process (GO:0044597) | 3.82137559 |
| 56 | alpha-linolenic acid metabolic process (GO:0036109) | 3.81427180 |
| 57 | tricarboxylic acid metabolic process (GO:0072350) | 3.81390254 |
| 58 | acylglycerol homeostasis (GO:0055090) | 3.79709902 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.79709902 |
| 60 | positive regulation of glucose import (GO:0046326) | 3.78008296 |
| 61 | cellular response to lithium ion (GO:0071285) | 3.76674430 |
| 62 | alditol metabolic process (GO:0019400) | 3.71393954 |
| 63 | fatty acid beta-oxidation (GO:0006635) | 3.70701608 |
| 64 | phosphatidic acid metabolic process (GO:0046473) | 3.69933326 |
| 65 | phosphatidic acid biosynthetic process (GO:0006654) | 3.69933326 |
| 66 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.63918690 |
| 67 | cellular response to leptin stimulus (GO:0044320) | 3.61918463 |
| 68 | polyol transport (GO:0015791) | 3.59435773 |
| 69 | positive regulation of glycolytic process (GO:0045821) | 3.56893241 |
| 70 | negative regulation of appetite (GO:0032099) | 3.46811685 |
| 71 | negative regulation of response to food (GO:0032096) | 3.46811685 |
| 72 | negative regulation of metanephros development (GO:0072217) | 3.46006478 |
| 73 | response to vitamin E (GO:0033197) | 3.44123054 |
| 74 | positive regulation of cholesterol efflux (GO:0010875) | 3.43142787 |
| 75 | response to phenylpropanoid (GO:0080184) | 3.42002846 |
| 76 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.41249150 |
| 77 | negative regulation of protein autophosphorylation (GO:0031953) | 3.41015814 |
| 78 | regulation of receptor binding (GO:1900120) | 3.40586062 |
| 79 | protein localization to cell surface (GO:0034394) | 3.39228131 |
| 80 | primary alcohol catabolic process (GO:0034310) | 3.39112599 |
| 81 | fatty acid catabolic process (GO:0009062) | 3.38404603 |
| 82 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.36344081 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.36133486 |
| 84 | L-phenylalanine catabolic process (GO:0006559) | 3.36133486 |
| 85 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.35291399 |
| 86 | endocrine hormone secretion (GO:0060986) | 3.34290124 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 3.32727160 |
| 88 | L-phenylalanine metabolic process (GO:0006558) | 3.32527654 |
| 89 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.32527654 |
| 90 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.32310268 |
| 91 | response to epinephrine (GO:0071871) | 3.31659402 |
| 92 | fatty acid transmembrane transport (GO:1902001) | 3.28759435 |
| 93 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.27500428 |
| 94 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.26368580 |
| 95 | positive regulation of fatty acid oxidation (GO:0046321) | 3.24173093 |
| 96 | regulation of triglyceride catabolic process (GO:0010896) | 3.23872755 |
| 97 | regulation of lipid catabolic process (GO:0050994) | 3.23577157 |
| 98 | adult feeding behavior (GO:0008343) | 3.21127350 |
| 99 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.20772865 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 10.5123903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.81903063 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.17361233 |
| 3 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.15959146 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44732815 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.34479230 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.28449006 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.18316682 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.13509910 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.93268718 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.61011471 |
| 11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.03191826 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 12.7578792 |
| 13 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.97196814 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75714358 |
| 15 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71350510 |
| 16 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.68288742 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.62205731 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57611174 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.54363073 |
| 20 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.54363073 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51638806 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46095451 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39024503 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33515530 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.31090825 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.31090825 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23412845 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22733558 |
| 29 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.22207732 |
| 30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18655731 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17682764 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13782873 |
| 33 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.13168960 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13022923 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12402303 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10820630 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10692907 |
| 38 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10387158 |
| 39 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.09367873 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08624909 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04948358 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03840223 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03206447 |
| 44 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02867021 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02719006 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01139347 |
| 47 | CBP_21632823_ChIP-Seq_H3396_Human | 0.98752502 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98049820 |
| 49 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97778498 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96174765 |
| 51 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94766278 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91442102 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89257427 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88662558 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88527259 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88240126 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88094172 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87795302 |
| 59 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.86826797 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83288340 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82993505 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82519717 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81418061 |
| 64 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80811854 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80766315 |
| 66 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79492126 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79043774 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78819100 |
| 69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.78004917 |
| 70 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.76933884 |
| 71 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.76884027 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74670337 |
| 73 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74499022 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74308382 |
| 75 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.74006069 |
| 76 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.73509864 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71773615 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.71569858 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70304532 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68415184 |
| 81 | SA1_27219007_Chip-Seq_Bcells_Human | 0.67689829 |
| 82 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.67428984 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67297918 |
| 84 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.67173325 |
| 85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66857751 |
| 86 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.66687740 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66264486 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65791897 |
| 89 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.65747195 |
| 90 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.65700823 |
| 91 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.65588866 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.65455704 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 0.64985735 |
| 94 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.64938661 |
| 95 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.64103197 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63969276 |
| 97 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.63574528 |
| 98 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.61348005 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61181053 |
| 100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59762110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.41981078 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.91147278 |
| 3 | MP0004130_abnormal_muscle_cell | 5.01982019 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 4.80030422 |
| 5 | MP0002971_abnormal_brown_adipose | 4.39602361 |
| 6 | MP0005375_adipose_tissue_phenotype | 4.27585636 |
| 7 | MP0002876_abnormal_thyroid_physiology | 3.32235862 |
| 8 | MP0009115_abnormal_fat_cell | 3.25570682 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.99771594 |
| 10 | MP0003959_abnormal_lean_body | 2.68629004 |
| 11 | MP0002970_abnormal_white_adipose | 2.62323649 |
| 12 | MP0005334_abnormal_fat_pad | 2.50682102 |
| 13 | MP0003011_delayed_dark_adaptation | 2.46406597 |
| 14 | MP0000003_abnormal_adipose_tissue | 2.46294769 |
| 15 | MP0003186_abnormal_redox_activity | 2.43910869 |
| 16 | MP0005535_abnormal_body_temperature | 2.36450011 |
| 17 | MP0003724_increased_susceptibility_to | 2.16480334 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.06179132 |
| 19 | MP0005503_abnormal_tendon_morphology | 2.00468730 |
| 20 | MP0003828_pulmonary_edema | 1.93303749 |
| 21 | MP0006138_congestive_heart_failure | 1.92383190 |
| 22 | MP0001661_extended_life_span | 1.90144179 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.89900836 |
| 24 | MP0003868_abnormal_feces_composition | 1.86437973 |
| 25 | MP0003690_abnormal_glial_cell | 1.85811123 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 1.81459241 |
| 27 | MP0005448_abnormal_energy_balance | 1.78414313 |
| 28 | MP0005452_abnormal_adipose_tissue | 1.59460657 |
| 29 | MP0002638_abnormal_pupillary_reflex | 1.52814716 |
| 30 | MP0005365_abnormal_bile_salt | 1.46637417 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.45887729 |
| 32 | MP0005275_abnormal_skin_tensile | 1.45852714 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.44531539 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.42849437 |
| 35 | MP0002078_abnormal_glucose_homeostasis | 1.35628979 |
| 36 | MP0001881_abnormal_mammary_gland | 1.24689657 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.23606567 |
| 38 | MP0005385_cardiovascular_system_phenoty | 1.22219540 |
| 39 | MP0001544_abnormal_cardiovascular_syste | 1.22219540 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.19024982 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.16183645 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.13520568 |
| 43 | MP0000609_abnormal_liver_physiology | 1.12090651 |
| 44 | MP0000343_altered_response_to | 1.10505657 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.06561914 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.05816978 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.02182265 |
| 48 | MP0001764_abnormal_homeostasis | 1.02055758 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.00784979 |
| 50 | MP0005647_abnormal_sex_gland | 0.99242733 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 0.96541761 |
| 52 | MP0000751_myopathy | 0.94727942 |
| 53 | MP0001727_abnormal_embryo_implantation | 0.94517021 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 0.94116247 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90996602 |
| 56 | MP0003948_abnormal_gas_homeostasis | 0.87942711 |
| 57 | MP0005595_abnormal_vascular_smooth | 0.85688787 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 0.85232805 |
| 59 | MP0002796_impaired_skin_barrier | 0.85227795 |
| 60 | MP0000759_abnormal_skeletal_muscle | 0.84939962 |
| 61 | MP0001501_abnormal_sleep_pattern | 0.83678488 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 0.83456730 |
| 63 | MP0000858_altered_metastatic_potential | 0.79876863 |
| 64 | MP0003953_abnormal_hormone_level | 0.79012897 |
| 65 | MP0004087_abnormal_muscle_fiber | 0.78520786 |
| 66 | MP0005164_abnormal_response_to | 0.78362795 |
| 67 | MP0000249_abnormal_blood_vessel | 0.75551165 |
| 68 | MP0002933_joint_inflammation | 0.74466864 |
| 69 | MP0004272_abnormal_basement_membrane | 0.73810476 |
| 70 | MP0002295_abnormal_pulmonary_circulatio | 0.70803256 |
| 71 | MP0000230_abnormal_systemic_arterial | 0.70228362 |
| 72 | MP0009643_abnormal_urine_homeostasis | 0.69616036 |
| 73 | MP0005332_abnormal_amino_acid | 0.65953515 |
| 74 | MP0001944_abnormal_pancreas_morphology | 0.65593588 |
| 75 | MP0005266_abnormal_metabolism | 0.62587976 |
| 76 | MP0004858_abnormal_nervous_system | 0.60953374 |
| 77 | MP0008775_abnormal_heart_ventricle | 0.60012736 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.59212397 |
| 79 | MP0000627_abnormal_mammary_gland | 0.59021710 |
| 80 | MP0003279_aneurysm | 0.58787408 |
| 81 | MP0003075_altered_response_to | 0.57687031 |
| 82 | MP0001177_atelectasis | 0.56851323 |
| 83 | MP0009672_abnormal_birth_weight | 0.56836776 |
| 84 | MP0003879_abnormal_hair_cell | 0.54993974 |
| 85 | MP0005360_urolithiasis | 0.54484647 |
| 86 | MP0002133_abnormal_respiratory_system | 0.54348529 |
| 87 | MP0005388_respiratory_system_phenotype | 0.54348529 |
| 88 | MP0002972_abnormal_cardiac_muscle | 0.49172773 |
| 89 | MP0005620_abnormal_muscle_contractility | 0.47893562 |
| 90 | MP0010630_abnormal_cardiac_muscle | 0.44936814 |
| 91 | MP0003448_altered_tumor_morphology | 0.44214885 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.42132374 |
| 93 | MP0000598_abnormal_liver_morphology | 0.41403189 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.40441307 |
| 95 | MP0000749_muscle_degeneration | 0.40303465 |
| 96 | MP0000747_muscle_weakness | 0.39774694 |
| 97 | MP0000163_abnormal_cartilage_morphology | 0.37011069 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.36540572 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.35788453 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.35339620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 8.47043273 |
| 2 | Acanthosis nigricans (HP:0000956) | 8.07386080 |
| 3 | Hypertriglyceridemia (HP:0002155) | 7.51026676 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 5.01361580 |
| 5 | Insulin resistance (HP:0000855) | 4.85811269 |
| 6 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.66440230 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.36938499 |
| 8 | Long foot (HP:0001833) | 4.12741267 |
| 9 | Abnormal eating behavior (HP:0100738) | 4.08920394 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.98867836 |
| 11 | Hemorrhage of the eye (HP:0011885) | 3.87124643 |
| 12 | Complement deficiency (HP:0004431) | 3.82224829 |
| 13 | Growth hormone excess (HP:0000845) | 3.80099360 |
| 14 | Increased variability in muscle fiber diameter (HP:0003557) | 3.68533059 |
| 15 | Nausea (HP:0002018) | 3.65992154 |
| 16 | Hypercortisolism (HP:0001578) | 3.63769710 |
| 17 | Myocardial infarction (HP:0001658) | 3.63063589 |
| 18 | Epidermoid cyst (HP:0200040) | 3.62022487 |
| 19 | Pigmentary retinal degeneration (HP:0001146) | 3.58431345 |
| 20 | Bone cyst (HP:0012062) | 3.54404729 |
| 21 | Skin nodule (HP:0200036) | 3.41898715 |
| 22 | Polyphagia (HP:0002591) | 3.26274324 |
| 23 | Ileus (HP:0002595) | 3.24712497 |
| 24 | Abnormal hemoglobin (HP:0011902) | 3.24200649 |
| 25 | Increased serum pyruvate (HP:0003542) | 3.23660829 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.22264826 |
| 27 | Vertebral compression fractures (HP:0002953) | 3.19631192 |
| 28 | Colitis (HP:0002583) | 3.16912284 |
| 29 | Increased muscle lipid content (HP:0009058) | 3.16400496 |
| 30 | Back pain (HP:0003418) | 3.10629418 |
| 31 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.09418447 |
| 32 | Abnormality of complement system (HP:0005339) | 3.08995252 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.03808347 |
| 34 | Xanthomatosis (HP:0000991) | 3.03783643 |
| 35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99879891 |
| 36 | Subcapsular cataract (HP:0000523) | 2.98178077 |
| 37 | Neonatal hypoglycemia (HP:0001998) | 2.94928520 |
| 38 | Difficulty running (HP:0009046) | 2.86753891 |
| 39 | Abnormality of glycolysis (HP:0004366) | 2.85854551 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.84079402 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.81479256 |
| 42 | Prominent supraorbital ridges (HP:0000336) | 2.79336135 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.73480449 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.70148217 |
| 45 | Polar cataract (HP:0010696) | 2.63300735 |
| 46 | Polycythemia (HP:0001901) | 2.53045580 |
| 47 | Accelerated skeletal maturation (HP:0005616) | 2.47543647 |
| 48 | Retinal atrophy (HP:0001105) | 2.41634003 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.41266178 |
| 50 | Muscle fiber splitting (HP:0003555) | 2.40289218 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.34467961 |
| 52 | Axonal loss (HP:0003447) | 2.33855094 |
| 53 | Cervical subluxation (HP:0003308) | 2.33686133 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.28950457 |
| 55 | Hyperalaninemia (HP:0003348) | 2.28950457 |
| 56 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28950457 |
| 57 | Frequent falls (HP:0002359) | 2.26487265 |
| 58 | Glomerulonephritis (HP:0000099) | 2.23672004 |
| 59 | Lipoatrophy (HP:0100578) | 2.21997279 |
| 60 | Amyloidosis (HP:0011034) | 2.19963441 |
| 61 | Steatorrhea (HP:0002570) | 2.18274254 |
| 62 | Ectopia lentis (HP:0001083) | 2.14194127 |
| 63 | Large hands (HP:0001176) | 2.13412156 |
| 64 | Spinal rigidity (HP:0003306) | 2.12099630 |
| 65 | Hyperparathyroidism (HP:0000843) | 2.07703600 |
| 66 | Atrioventricular block (HP:0001678) | 2.05533225 |
| 67 | Lymphangioma (HP:0100764) | 2.04324131 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.01915247 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01915247 |
| 70 | Joint hemorrhage (HP:0005261) | 2.01862814 |
| 71 | Pancreatitis (HP:0001733) | 2.01306711 |
| 72 | Hypophosphatemic rickets (HP:0004912) | 1.97994206 |
| 73 | Aortic aneurysm (HP:0004942) | 1.96951061 |
| 74 | Mutism (HP:0002300) | 1.95455859 |
| 75 | Striae distensae (HP:0001065) | 1.93196037 |
| 76 | Toxemia of pregnancy (HP:0100603) | 1.92221220 |
| 77 | Renal Fanconi syndrome (HP:0001994) | 1.92184245 |
| 78 | Vascular tortuosity (HP:0004948) | 1.91539078 |
| 79 | Rickets (HP:0002748) | 1.91353533 |
| 80 | Multiple lipomas (HP:0001012) | 1.90646930 |
| 81 | Polygenic inheritance (HP:0010982) | 1.89108193 |
| 82 | Fat malabsorption (HP:0002630) | 1.88211823 |
| 83 | Rhabdomyolysis (HP:0003201) | 1.88204398 |
| 84 | Hepatic necrosis (HP:0002605) | 1.85490028 |
| 85 | Abnormality of carpal bone ossification (HP:0006257) | 1.81338036 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 1.80471081 |
| 87 | Hyperpituitarism (HP:0010514) | 1.73728438 |
| 88 | Fused cervical vertebrae (HP:0002949) | 1.73172981 |
| 89 | Generalized aminoaciduria (HP:0002909) | 1.73032353 |
| 90 | Gowers sign (HP:0003391) | 1.71920023 |
| 91 | Metaphyseal dysplasia (HP:0100255) | 1.71655114 |
| 92 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.71445427 |
| 93 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.71445427 |
| 94 | Abnormal cartilage morphology (HP:0002763) | 1.68865109 |
| 95 | Shallow orbits (HP:0000586) | 1.68469242 |
| 96 | Adrenal overactivity (HP:0002717) | 1.67800577 |
| 97 | Paralysis (HP:0003470) | 1.67308224 |
| 98 | Neck muscle weakness (HP:0000467) | 1.66978011 |
| 99 | Exocrine pancreatic insufficiency (HP:0001738) | 1.66573949 |
| 100 | Neonatal onset (HP:0003623) | 1.64599605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.64514493 |
| 2 | EPHB2 | 3.97126923 |
| 3 | DDR2 | 3.84407194 |
| 4 | CAMK1D | 3.24284727 |
| 5 | TIE1 | 3.22903491 |
| 6 | TESK1 | 2.76355263 |
| 7 | ARAF | 2.71478885 |
| 8 | TGFBR2 | 2.70955969 |
| 9 | SIK1 | 2.62286401 |
| 10 | PRKAA2 | 2.50853142 |
| 11 | MYLK | 2.49764032 |
| 12 | RIPK4 | 2.44208062 |
| 13 | RIPK1 | 2.42464206 |
| 14 | CAMK1G | 2.32536015 |
| 15 | CAMK1 | 2.31332298 |
| 16 | ABL2 | 2.17706822 |
| 17 | LATS2 | 2.08268829 |
| 18 | GRK5 | 2.05952804 |
| 19 | ERN1 | 1.98965958 |
| 20 | CDK6 | 1.87116731 |
| 21 | CAMKK2 | 1.76795565 |
| 22 | LATS1 | 1.76056766 |
| 23 | MAPK4 | 1.57217776 |
| 24 | MAP3K13 | 1.55316173 |
| 25 | MOS | 1.37159914 |
| 26 | EEF2K | 1.36692660 |
| 27 | MAP2K1 | 1.34323246 |
| 28 | SCYL2 | 1.28083058 |
| 29 | MAP3K9 | 1.24539337 |
| 30 | ILK | 1.18534427 |
| 31 | PRKD3 | 1.13141540 |
| 32 | PDPK1 | 1.12116955 |
| 33 | AKT3 | 1.11242085 |
| 34 | ADRBK1 | 1.08883581 |
| 35 | PKN1 | 1.08593954 |
| 36 | PDGFRA | 1.08504270 |
| 37 | PKN2 | 1.06787449 |
| 38 | MAP3K6 | 1.06422346 |
| 39 | NEK9 | 1.04086688 |
| 40 | MAPKAPK3 | 1.03170567 |
| 41 | PRKAA1 | 0.96511421 |
| 42 | CDK9 | 0.96430158 |
| 43 | FER | 0.95750657 |
| 44 | MAPK12 | 0.94685699 |
| 45 | STK38 | 0.91250790 |
| 46 | PRKACG | 0.90203550 |
| 47 | PINK1 | 0.88323647 |
| 48 | CSK | 0.87326988 |
| 49 | YES1 | 0.83737515 |
| 50 | CDK4 | 0.81144664 |
| 51 | JAK2 | 0.80479446 |
| 52 | STK38L | 0.78419126 |
| 53 | MAPKAPK5 | 0.75964983 |
| 54 | GSK3A | 0.75591660 |
| 55 | TNK2 | 0.71128867 |
| 56 | KSR2 | 0.69765424 |
| 57 | PDGFRB | 0.68615151 |
| 58 | PDK1 | 0.65331532 |
| 59 | PRKG1 | 0.63622441 |
| 60 | CAMKK1 | 0.62090060 |
| 61 | IGF1R | 0.61446811 |
| 62 | LRRK2 | 0.59211870 |
| 63 | RET | 0.59182761 |
| 64 | PDK2 | 0.57816805 |
| 65 | GRK1 | 0.55343769 |
| 66 | PRPF4B | 0.55045302 |
| 67 | PAK2 | 0.55000385 |
| 68 | FES | 0.54318739 |
| 69 | WNK4 | 0.54033934 |
| 70 | TRPM7 | 0.53564540 |
| 71 | BRAF | 0.52638084 |
| 72 | TYRO3 | 0.52125492 |
| 73 | MAPK3 | 0.50923663 |
| 74 | CDK5 | 0.48534517 |
| 75 | DAPK3 | 0.45762251 |
| 76 | KDR | 0.45347609 |
| 77 | EIF2AK2 | 0.43933705 |
| 78 | NLK | 0.43804901 |
| 79 | PTK2 | 0.42903229 |
| 80 | ABL1 | 0.41930001 |
| 81 | MAP2K4 | 0.40064408 |
| 82 | TYK2 | 0.39945362 |
| 83 | BCKDK | 0.38611266 |
| 84 | PRKACB | 0.36826873 |
| 85 | RPS6KA3 | 0.35726446 |
| 86 | JAK1 | 0.35233375 |
| 87 | PRKD1 | 0.33292135 |
| 88 | MAP3K11 | 0.31562844 |
| 89 | AKT2 | 0.30765160 |
| 90 | INSR | 0.29409129 |
| 91 | SGK494 | 0.29062985 |
| 92 | SGK223 | 0.29062985 |
| 93 | SGK2 | 0.28417918 |
| 94 | PRKACA | 0.27313415 |
| 95 | PIK3CA | 0.26873531 |
| 96 | SRC | 0.26189873 |
| 97 | MAPK7 | 0.24526983 |
| 98 | CAMK4 | 0.24389365 |
| 99 | MTOR | 0.23663713 |
| 100 | PAK1 | 0.22758816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.49630908 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.37368481 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.92675424 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.84005014 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.30660407 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.17125823 |
| 7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.10108812 |
| 8 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.94562836 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.71139896 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.60257144 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.51593624 |
| 12 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.46939281 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.32694792 |
| 14 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.31983311 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30658388 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.22813879 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20598664 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19244664 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10697522 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.97039855 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.90591870 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.86760657 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55359102 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.46590346 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38272606 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.32828261 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27419414 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26608790 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19282176 |
| 30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16249993 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11932025 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.06161744 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00161704 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93201548 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90477341 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90315392 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88777048 |
| 38 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88162387 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85803440 |
| 40 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82083971 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81959366 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76178406 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74667069 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74204173 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 0.73828637 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68519406 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67526498 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 0.66964552 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66444749 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65137019 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64806232 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63101848 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62851566 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58074744 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56730681 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.55286951 |
| 57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54921144 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54340625 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49699932 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47596253 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46866355 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46535330 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46518409 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45209491 |
| 65 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42305738 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41031624 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35242125 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33077956 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.32689627 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31573618 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.30995131 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29619840 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25386788 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.23729676 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23400263 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23237198 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20725467 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.20303673 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19756393 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.18225990 |
| 81 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.15953291 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.13606876 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.13071875 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12423353 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.12150120 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.11924199 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.08819116 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.08193879 |
| 89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.07790525 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.07218485 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.06421728 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.06298633 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.06187348 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.04029783 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.03233946 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.01965388 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.01065959 |
| 98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.00637074 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0219661 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0152996 |

